Last reviewed · How we verify

Combination of antibiotics

Assistance Publique - Hôpitaux de Paris · Phase 3 active Small molecule

Combination of antibiotics is a Antibiotic combination Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 3 development for Bacterial infections (specific indication not publicly detailed for this Phase 3 combination). Also known as: Ceftriaxone; clarithromycin, metronidazole.

A combination of antibiotics that work synergistically to inhibit bacterial cell wall synthesis and protein production, targeting multiple pathways to overcome resistance.

A combination of antibiotics that work synergistically to inhibit bacterial cell wall synthesis and protein production, targeting multiple pathways to overcome resistance. Used for Bacterial infections (specific indication not publicly detailed for this Phase 3 combination).

At a glance

Generic nameCombination of antibiotics
Also known asCeftriaxone; clarithromycin, metronidazole
SponsorAssistance Publique - Hôpitaux de Paris
Drug classAntibiotic combination
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhasePhase 3

Mechanism of action

Antibiotic combinations typically pair agents with different mechanisms—such as beta-lactams that disrupt peptidoglycan cross-linking with aminoglycosides or fluoroquinolones that inhibit DNA gyrase—to achieve broader spectrum coverage and reduce the emergence of resistant strains. This approach is particularly valuable in treating polymicrobial infections or infections caused by multidrug-resistant organisms where monotherapy may be insufficient.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Combination of antibiotics

What is Combination of antibiotics?

Combination of antibiotics is a Antibiotic combination drug developed by Assistance Publique - Hôpitaux de Paris, indicated for Bacterial infections (specific indication not publicly detailed for this Phase 3 combination).

How does Combination of antibiotics work?

A combination of antibiotics that work synergistically to inhibit bacterial cell wall synthesis and protein production, targeting multiple pathways to overcome resistance.

What is Combination of antibiotics used for?

Combination of antibiotics is indicated for Bacterial infections (specific indication not publicly detailed for this Phase 3 combination).

Who makes Combination of antibiotics?

Combination of antibiotics is developed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).

Is Combination of antibiotics also known as anything else?

Combination of antibiotics is also known as Ceftriaxone; clarithromycin, metronidazole.

What drug class is Combination of antibiotics in?

Combination of antibiotics belongs to the Antibiotic combination class. See all Antibiotic combination drugs at /class/antibiotic-combination.

What development phase is Combination of antibiotics in?

Combination of antibiotics is in Phase 3.

What are the side effects of Combination of antibiotics?

Common side effects of Combination of antibiotics include Gastrointestinal disturbance, Allergic reaction, Nephrotoxicity, Ototoxicity.

Related